Molecular Omics is a premier, peer-reviewed journal published by the Royal Society of Chemistry, focusing on the interdisciplinary field of molecular biology with significant implications for biochemistry and genetics. With an E-ISSN of 2515-4184, this journal has been dedicated to disseminating high-quality research since its inception in 2018, maintaining an impressive trajectory in academic contributions until 2024. Currently, it holds a Q2 quartile ranking in both Biochemistry and Genetics, alongside a Q3 ranking in Molecular Biology for 2023, highlighting its relevance and influence in these domains. The journal is accessible as an open access publication, promoting the widespread dissemination of groundbreaking research. As part of a vibrant academic community, Molecular Omics aims to bridge fundamental and applied science, appealing to researchers, professionals, and students eager to expand their knowledge on molecular mechanisms and technologies that shape the future of biological research.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

MASS SPECTROMETRY REVIEWS, published by Wiley, is a premier academic journal dedicated to advancing the field of mass spectrometry and its applications across a multitude of scientific disciplines. With an ISSN of 0277-7037 and an E-ISSN of 1098-2787, the journal has established itself as a vital resource within the realms of Analytical Chemistry, Biochemistry, Genetics, Condensed Matter Physics, and Spectroscopy, achieving Q1 status across these categories in 2023. As a testament to its significant contribution to scholarly research, it boasts impressive Scopus rankings, including a rank of #2 out of 76 in Chemistry - Spectroscopy and #4 out of 156 in Chemistry - Analytical Chemistry, placing it in the 97th percentile and above. Emphasizing high-quality, peer-reviewed research, MASS SPECTROMETRY REVIEWS serves as an essential platform for researchers, professionals, and students aiming to stay abreast of cutting-edge developments and methodologies in mass spectrometry. The journal is committed to fostering a deeper understanding of mass spectrometric techniques while also contributing to interdisciplinary advancements, making it a valuable addition to any academic library. Authors seeking to disseminate their work in a journal with a strong reputation and impact in the scientific community will find MASS SPECTROMETRY REVIEWS an ideal venue.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, published by Elsevier Science Ltd, is a premier scholarly journal dedicated to advancing the field of cardiology and cardiovascular medicine as well as molecular biology. With an impressive Q1 ranking in both categories as of 2023, the journal boasts a significant influence in the scientific community, evidenced by its Scopus rankings—33rd out of 387 in Cardiology and 65th out of 410 in Molecular Biology. Established in 1970 and continuing to publish groundbreaking research through 2024, the journal’s mission is to disseminate innovative findings that enhance our understanding of cardiovascular health at the molecular and cellular levels. Although it is not an open-access publication, it attracts top-tier research contributions, making it essential reading for researchers, healthcare professionals, and students aiming to stay ahead in the dynamic domains of cardiovascular and molecular biology research.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, published by Elsevier, is a prestigious academic journal that serves as a vital resource for researchers, professionals, and students in the fields of biochemistry, biophysics, and proteomics. With an ISSN of 1570-9639 and an E-ISSN of 1878-1454, this journal features high-impact research articles aimed at advancing our understanding of protein structure, function, and interactions, contributing significantly to both theoretical and applied sciences. Recognized for its quality, it proudly holds a Q1 ranking in Analytical Chemistry and Biophysics, and Q2 in Biochemistry for 2023, alongside notable Scopus rankings that reflect its influence in the realm of molecular biology. The journal's commitment to disseminating essential findings supports the ongoing evolution of proteomic sciences and encourages collaborative discourse among the global scientific community. For aspiring authors, the journal offers open access options, enabling broad visibility of their work. Join the conversation in this dynamic field and contribute to shaping the future of protein research!

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

Proteome Science is an esteemed academic journal specializing in the field of proteomics, providing a platform for advanced research and discussions surrounding the structure, function, and dynamics of proteins in biological systems. Published by BMC, a reputable publisher recognized for its commitment to open-access publishing, Proteome Science has been disseminating pivotal research findings since its inception in 2003. Targeted towards researchers, professionals, and students in biochemistry and molecular biology, the journal aims to foster collaboration and innovation within the scientific community. While it currently holds a Q3 quartile ranking in both Biochemistry and Molecular Biology categories, its impactful contributions to the field are reflected in its accessibility, as evidenced by its open access policy. By embracing collaborative research methodologies and providing a platform for novel findings, Proteome Science plays a crucial role in advancing the understanding of proteomic analyses, catering to a global audience that values groundbreaking scientific discovery.

GROWTH FACTORS, published by Taylor & Francis Ltd, is a prestigious journal dedicated to advancing the field of cell biology, clinical biochemistry, and endocrinology. With an ISSN of 0897-7194 and an E-ISSN of 1029-2292, this journal has served as a vital platform for the dissemination of groundbreaking research since its inception in 1988. Although it operates without an Open Access model, GROWTH FACTORS focuses on providing high-quality, peer-reviewed articles that explore the intricate roles of growth factors in biological processes and their implications in health and disease. Holding a Q4 ranking in Cell Biology and Q3 rankings in Clinical Biochemistry and Endocrinology according to the 2023 category quartiles, the journal is well-regarded in its field and plays a crucial role in informing researchers, professionals, and students alike about the latest findings and innovations in these areas. The journal's commitment to fostering scientific dialogue ensures that it remains a key resource for those looking to enhance their understanding of growth factors and their applications in clinical settings.

Bioinformatics and Biology Insights is a premier open-access journal dedicated to advancing the frontiers of bioinformatics and biology. Published by SAGE Publications Ltd, this journal is a leading platform for disseminating high-quality research that integrates computational methods with biological insights. Since its inception in 2007, the journal has garnered significant recognition, reflecting its commitment to excellence, as evidenced by its impressive impact factor and a strong presence across multiple quartiles in applied mathematics, biochemistry, and computational sciences. With a rank of Q1 in both Applied Mathematics and Computational Mathematics and various other notable rankings in related fields, it serves as an essential resource for researchers, professionals, and students seeking cutting-edge knowledge and innovations. The journal's open-access model ensures that findings are readily available, fostering collaboration and advancement in this dynamic field. Through its comprehensive scope and rigorous peer-review process, Bioinformatics and Biology Insights continues to play a pivotal role in shaping the future of biological research and computational methodologies.

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.